Results from a phase I clinical trial with IGN311, a fully humanized IgG1 antibody against Lewis Y in patients with solid tumors expressing Lewis Y antigen

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2624-2624 ◽  
Author(s):  
D. V. Oruzio ◽  
C. Aulmann ◽  
N. Eller ◽  
G. Mudde ◽  
O. Obwaller ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Igg1 Antibody ◽  
Lewis Y Antigen ◽  
Lewis Y

scholarly journals A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

2012 ◽  
Vol 70 (6) ◽  
pp. 843-853 ◽  
Author(s):  
Michael J. Pishvaian ◽  
Rebecca Slack ◽  
Eunice Y. Koh ◽  
Jan H. Beumer ◽  
Marion L. Hartley ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Standard Therapy ◽  
Phase I Clinical Trial

A phase I clinical trial of QBI-139, a human ribonuclease variant, in solid tumors.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS146-TPS146 ◽  
Author(s):  
L. E. Strong ◽  
J. A. Kink ◽  
B. Mei ◽  
M. N. Shahan ◽  
R. T. Raines
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial

Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2558-2558 ◽  
Author(s):  
Jennifer Rachel Eads ◽  
Smitha S. Krishnamurthi ◽  
Joel N. Saltzman ◽  
Neal J. Meropol ◽  
Joseph A. Bokar ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

First-in-human phase I clinical trial of NY-ESO-1 protein cancer vaccine with a novel adjuvant MIS416, NOD2 and TLR9 stimulant, for patients with NY-ESO-1 expressing solid tumors.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e15176-e15176 ◽  
Author(s):  
Mikiya Ishihara ◽  
Yasutaka Tono ◽  
Yoshihiro Miyahara ◽  
Naozumi Harada ◽  
Shinichi Kageyama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Cancer Vaccine ◽  
Phase I Clinical Trial

Regorafenib and nivolumab combination therapy for advanced and metastatic solid tumors: Phase I clinical trial (EPOC1603).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS3124-TPS3124
Author(s):  
Shota Fukuoka ◽  
Hiroki Hara ◽  
Satoshi Shimizu ◽  
Hideaki Takahashi ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Combination Therapy ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial

scholarly journals A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors

2007 ◽  
Vol 6 (5) ◽  
pp. 648-653 ◽  
Author(s):  
Xubin Lin ◽  
Huiqiang Huang ◽  
Su Li ◽  
Hongli Li ◽  
Yuhong Li ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document